Skip to main content
. 2022 Jan 24;10(1):e002579. doi: 10.1136/bmjdrc-2021-002579

Table 1.

Baseline characteristics of the study subjects

Parameter Patients F2) P value
DM DLEAD DCLI
n (%) 27 (26.2) 46 (44.7) 30 (29.1)
Male/female (n) 14/13 28/18 16/14 0.715 0.699
Age (years) 44.41±11.40 57.07±10.19 64.53±10.46 26.133 <0.001
BMI (kg/m2) 22.13±2.93 23.54±3.60 23.19±2.74 1.302 0.277
Course (%) 26.036 <0.001
 <5 years 23 (85.2) 15 (32.6) 8 (26.7)
 5–10 years 2 (7.4) 11 (23.9) 4 (13.3)
 ≥10 years 2 (7.4) 18 (39.1) 17 (56.7)
Smoking (%) 7 (25.9) 15 (32.6) 6 (20.0) 1.145 0.564
 Current 5 14 5
 Former 2 1 1
 Never 20 31 24
Hypertension (%) 7 (25.9) 19 (41.3) 18 (60.0) 8.314 0.016
Hyperlipidemia (%) 6 (22.2) 23 (50.0) 13 (43.3) 6.264 0.044
Family history (%) 3 (11.1) 19 (41.3) 5 (16.7) 9.936 0.007
2hPBG (mM) 10.51±4.41 11.67±3.91 9.75±5.12 1.616 0.205
GLU (mM) 7.65 (5.23–14.46) 7.11 (4.92–10.13) 9.41 (6.39–14.97) 2.699 0.259
HbA1c (mmol/mol) 9.70 (7.21–12.41) 9.25 (8.20–11.20) 7.80 (7.10–9.50) 4.205 0.122
CRP (mg/L) 1.12 (0.57–5.66) 2.40 (0.85–7.54) 21.35 (2.63–62.07) 12.601 0.002
TG (mM) 1.40 (1.06–2.53) 1.57 (0.94–2.44) 1.61 (1.28–2.77) 2.388 0.303
CHOL (mM) 4.87 (3.91–5.55) 4.22 (3.22–5.24) 3.77 (2.93–4.58) 7.465 0.024
HDL-C (mM) 1.09 (0.82–1.30) 0.94 (0.76–1.17) 0.84 (0.72–0.97) 5.832 0.054
LDL-C (mM) 3.09±0.88 2.67±0.94 2.43±1.05 3.237 0.044
WCC (×109/L) 6.66 (5.31–9.02) 7.61 (6.50–9.50) 8.74 (7.21–11.71) 7.171 0.028
Hb (g/L) 138.6 (128.5–145.5) 127.5 (113.0–143.0) 106.0 (85.0–118.5) 21.340 <0.001

Data are mean±SD or median (IQR).

BMI, body mass index; CHOL, cholesterol; CRP, C reactive protein; DCLI, diabetic critical limb ischemia; DLEAD, diabetic lower extremity arterial disease; DM, diabetes mellitus; GLU, glucose; Hb, hemoglobin; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; 2hPBG, 2-hour postprandial blood glucose; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; WCC, white cell count.